Maternal Inositol Status and Neural Tube Defects: A Role for the Human Yolk Sac in Embryonic Inositol Delivery?
Open Access
- 5 September 2020
- journal article
- review article
- Published by Elsevier in Advances in Nutrition
- Vol. 12 (1) , 212-222
Abstract
Supplementation with myo-inositol during the periconceptional period of pregnancy may ameliorate the recurrence risk of having a fetus affected by a neural tube defect (NTD; e.g., spina bifida). This could be of particular importance in providing a means for preventing NTDs that are unresponsive to folic acid. This review highlights the characteristics of inositol and describes the role of myo-inositol in the prevention of NTDs in rodent studies and the evidence for its efficacy in reducing NTD risk in human pregnancy. The possible reduction in NTD risk by maternal myo-inositol implies functional and developmentally important maternal–embryonic inositol interrelationships and also suggests that embryonic uptake of myo-inositol is crucial for embryonic development. The establishment of active myo-inositol cellular uptake mechanisms in the embryonic stages of human pregnancy, when the neural tube is closing, is likely to be an important determinant of normal development. We draw attention to the generation of materno-fetal inositol concentration gradients and relationships, and outline a transport pathway by which myo-inositol may be delivered to the early developing human embryo. These considerations provide novel insights into the mechanisms that may underpin inositol's ability to confer embryonic developmental benefit.Keywords
Funding Information
- Wellcome Trust (MR/R006237/1)
- NDEG (GN2656)
- National Institute for Health Research
- University College London
This publication has 123 references indexed in Scilit:
- Expression and immunolocalisation of the endocytic receptors megalin and cubilin in the human yolk sac and placenta across gestationPlacenta, 2013
- Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometryJournal of Chromatography B, 2011
- Paper 2: EUROCAT public health indicators for congenital anomalies in EuropeBirth Defects Research Part A: Clinical and Molecular Teratology, 2011
- Folic acid to reduce neonatal mortality from neural tube disordersInternational Journal of Epidemiology, 2010
- Genetics of human neural tube defectsHuman Molecular Genetics, 2009
- Evaluation of expression and function of the H+/myo-inositol transporter HMITBMC Cell Biology, 2009
- Regulation of folate receptor 1 gene expression in the visceral endodermBirth Defects Research Part A: Clinical and Molecular Teratology, 2009
- Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Microarray analysis of E9.5 reduced folate carrier (RFC1; Slc19a1) knockout embryos reveals altered expression of genes in the cubilin-megalin multiligand endocytic receptor complexBMC Genomics, 2008
- Neural tube defects and folate: case far from closedNature Reviews Neuroscience, 2006